| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |